|
Article Excerpt
With "launched the world's best-selling drug" on his resume, Rob Scott was ready for his next professional endeavour. The former Pfizer executive is now head of R&D and chief medical officer at Athero-Genics, named for the signature technology that's being used to develop AGI-1067, a cardiovascular anti-inflammatory in late Phase III clinical trials.
Scott still gets his Big Pharma fix--AtheroGenics partnered in December 2005 with AstraZeneca to commercialize AG-1067--but the South Africa native feels right at home working for a smaller operation--on a big-time project.
Pharm Exec: When did you first know that Lipitor was going to be successful?
Rob Scott: We used to hold these R&D days at Pfizer, when we'd talk about where we should be going, which drugs we should be trying to develop, which approaches we should be trying to follow. About a year before we did the deal [Pfizer acquired Parke-Davis, developer of Lipitor, when it bought Warner-Lambert in 2000], we were reviewing a bunch of approaches that Pfizer had. And every time we looked at an approach, people would say, "Well, that's not going to work out so well if Lipitor makes it to the market." And said, "Well, we should try and get Lipitor, then."
We were going to be launching against other companies with deep pockets, that had outcomes...
|
|
More articles from Pharmaceutical Executive
Make beautiful music together: one brand message, multiple agencies: h..., October 01, 2006
Judge a drug by its cover: five tips for better product packaging.(BAC..., October 01, 2006
Going to court: where you file that patent lawsuit matters. Over the p..., October 01, 2006
After Plan B: out of the quagmire, into the data: the morning-after pi..., October 01, 2006
Please come back: health authorities in Europe are working hard to ree..., October 01, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
